170799 ⎘
Detection or diagnosis of diseases; Endocrine or metabolic disorders Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
Method for determining insulin sensitivity with biomarkers
#902Compositions and methods for the prevention and treatment of autoimmune conditions
#903Compositions and methods for treatment of diabetic retinopathy
#904SECRETED AND TRANSMEMBRANE POLYPEPTIDES AND NUCLEIC ACIDS ENCODING THE SAME
#905Methods of diagnosis and treatment of metabolic disorders
#906Breath test device and method
#907Diagnosis and treatment of type 2 diabetes and other disorders
#908Characterization and identification of unique human adiponectin isoforms and antibodies
#909Method for identifying type I diabetes mellitus in humans
#910METHOD OF SCREENING FOR DISORDERS OF GLUCOSE METABOLISM
#911LXR ligand testing method
#912Glycated peptides and methods of use
#913Peptide biomarkers predictive of renal function decline and kidney disease
#914Methods for identifying compounds for the treatment of type 1 diabetes
#915Methods of treatment of renal disease
#916Inositol pyrophosphates determine exocytotic capacity
#917Methods for Identifying Compounds for the Treatment of Type 1 Diabetes
#918Rage Fusion Proteins and Methods of Use
#919Isolated nucleic acids and polypeptides associated with glucose homeostasis disorders and method of detecting the same
#920Use of the AXL receptor for diagnosis and treatment of renal disease
#921METHOD OF DETECTING MILD IMPAIRED GLUCOSE TOLERANCE OR INSULIN SECRETORY DEFECT
#922Assays for erectile and bladder dysfunction and vascular health
#923Method for identifying target protein of drug and method for screening therapeutic agent for diabetes using the target protein
#924CAP/SORBS1 AND DIABETES
#925NPC1L1 AND NPC1L1 INHIBITORS AND METHODS OF USE THEREOF
#926Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
#927Reagent and kit for early diagnosis of kidney disease
#928METHOD OF SCREENING COMPOUND DIRECTLY ACTIVATING GLYCOGEN SYNTHASE
#929Diabetes-related biomarkers and methods of use thereof
#930Rage Fusion Proteins And Methods Of Use
#931Diabetes model animal
#932Method system and device for assessing insulin sensitivity
#933GLYCEROL AS A PREDICTOR OF GLUCOSE TOLERANCE
#934METHODS OF USING MULTIVALENT MHC CLASS II-PEPTIDE CHIMERAS
#935Methods of Modulating Beta Cell Function
#936Uses of notch receptors, notch ligands, and notch modulators in methods related to metabolic diseases
#937Method for activating efferent sympathetic nerves innervating adipose tissues to improve obesity and symptoms associated therewith
#938Method of evaluation of the relative risk of developing atherosclerosis in patients
#939Antibody Reactive Specifically to Age Derived from 3,4-Dge
#940Megsin/Rage/Inos-Overexpressing Renal Disease Model Animals and Methods for Evaluating Compounds Using the Model Animals
#941Methods and kits for the diagnosis of galactosemia
#942Methods for modulating cholecystokinin expression
#943Sirtuin polymorphisms and methods of use thereof
#944Methods and compositions for determination of glycated proteins
#945Cross-β structure comprising amyloid-binding proteins and methods for detection of the cross-β structure, for modulating cross-β structures fiber formation and modulating cross-β structure-mediated toxicity
#946Methods for identifying, isolating, and utilizing endocrine progenitor cells from adult human pancreata
#947GENE EXPRESSION IN PERIPHERAL BLOOD MONONUCLEAR CELLS FROM CHILDREN WITH DIABETES
#948Drug Screen and Treatment Method
#949SCREENING FOR GESTATIONAL DISORDERS
#950Method of predicting a benefit of antioxidant therapy for prevention or treatment of vasclar disease in hyperglycemic individuals
#951Genes Associated With Type ll Diabetes Mellitus
#952DEVICE AND METHOD FOR AUTOMATIC DATA ACQUISITION AND/OR DETECTION
#953Methods for the Treatment of Autoimmune Diseases
#954Tumor Suppressor Lkb1 Kinase Directly Activates Amp-Activated Kinase
#955ASSAY FOR DIABETES
#956Method of estimation of blood glucose excursions in diabetic patients using 1,5-anhydroglucitol (1,5-AG) assay
#957Treatment of insulin resistance
#958Methods, Kits and Materials for Diagnosing Disease States by Measuring Isoforms or Proforms of Myeloperoxidase
#959Method for assessing arteriosclerosis and diabetic nephropathy
#960Drug Identification and Treatment Method
#961Drug screening and treatment methods
#962METHOD FOR DIAGNOSING DIABETES IN A MAMMAL
#963Compositions and methods for modulation of KSR1 and KSR2 interactions
#964Novel Use of the Kinases Rsk4 and Pak5
#965PREDICTING DIABETIC NEPHROPATHY
#966Apparatus and process for stroke examination and treatment using a C-arch X-ray system
#967Method for evaluating insulin resistance
#968Thermoelectric sensor for analytes in a fluid and related method
#969SECRETED AND TRANSMEMBRANE POLYPEPTIDES AND NUCLEIC ACIDS ENCODING THE SAME
#970Methods of screening for TRPM4 modulators of insulin secretion
#971Diagnostic Methods Of Multiple Organ Amyloidosis
#972Antibodies against the PRO1754 polypeptides
#973Prediction and prophylactic treatment of type 1 diabetes
#974Method and composition for management of weight and blood sugar
#975Method for decreasing blood glucose and improving glucose tolerance using angiopoietin-like protein 4
#976Pharmaceutical Composition for Lowering Blood Sugar Level
#977Acetyl CoA Carboxylase Splice Variant and Uses Thereof
#978Prophylactic or therapeutic agent for diabetic maculopathy
#979Genes and markers in type 2 diabetes and obesity
#980Methods of identifying compounds for producing insulin sensitization
#981Anti-aging micrornas
#982Device and method for analysis of a metabolic malady
#983SECRETED AND TRANSMEMBRANE POLYPEPTIDES AND NUCLEIC ACIDS ENCODING THE SAME
#984Diagnosis and prognosis of dipeptidyl peptidase-associated disease states
#985Methods of treating diabetes
#986Methods, arrangements and systems for obtaining information associated with an anatomical sample using optical microscopy
#987Method of Screening Antidiabetic Agents
#988Human G protein-coupled receptor and modulators thereof for the treatment of hyperglycemia and related disorders
#989Distribution of PON1 as a marker of lipid related disorders
#990Methods and compositions for the diagnosis of treatment of type 2 diabetes
#991Secreted proteins as early markers and drug targets for autoimmunity, tumorigenesis and infections
#992Antibodies to the PRO1561 polypeptide
#993Diabetes-associated markers and methods of use thereof
#994Method of Predicting a Benefit of Antioxidant Therapy for Prevention of Cardiovascular Disease in Hiperglycemic Patients
#995Human Obesity Susceptibility Gene and Uses Thereof
#996Method of determining the susceptibility of a subject to developing insulin-dependent diabetes
#997Insulin-Independent, Bone Morphogenetic Protein (Bmp)-Mediated Uptake Of Blood Glucose By Peripheral Cells And Tissues
#998Targeted Drug-Formaldehyde Conjugates And Methods Of Making And Using The Same
#999Methods For Diagnosing And Treating Endoplasmic Reticulum (er) Stress Diseases
#1000Antagonist of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
#1001Inhibition of s6 kinaze activity for the treatment of insulin resistance
#1002Diabetogenic epitopes
#1003Pharmaceutical compositions and methods for metabolic modulation
#1004TIME-RESOLVED NON-INVASIVE OPTOMETRIC DEVICE FOR DETECTING DIABETES
#100550 Human secreted proteins
#1006Kits for assays of rapid screening of diabetes
#1007Methods of treating cancer, arthritis and/or diabetes with angiopoietins
#1008Association of polymorphic kinase anchor proteins with cardiac phenotypes and related methods
#1009Methods for detecting deficient cellular membrane tightly bound magnesium for disease diagnoses
#1010Insulin epitopes for the treatment of type 1 diabetes
#1011PREDICTIVE TREATMENT OF DYSGLYCEMIC EXCURSIONS ASSOCIATED WITH DIABETES MELLITUS
#1012GLP-1 agonists, compositions, methods and uses
#1013Genetically modified mouse lacking diacylglycerol acyltransferase-1 (DGAT-1) activity
#1014Methods of diagnosing and treating diabetes and insulin resistance
#1015Managing glycemia status in diabetic patients
#1016Predicting diabetic nephropathy
#1017Assay for diabetes
#1018antibodies binding to a C-terminal fragment of apoliopoprotein E
#1019Crystals of DPP-IV
#1020Method of identifying responders to treatment with insulin sensitizers
#1021Target protein of antidiabetic and novel antidiabetic insuful corresponding thereto
#1022Methods for identifying agents that modulate GPR105 activity
#1023Rapid serum sugar biomarker assay of rheumatoid arthritis
#1024Polypeptide
#1025Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level
#1026Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level
#1027Method for treatment of cardiovascular and metabolic diseases and detecting the risk of the same
#1028Apparatus and method for computer modeling type 1 diabetes
#1029Method of identifying agents to prevent or treat diabetes
#1030Methods for measuring the insulin receptor α subunit
#1031Novel genes and markers associated to type 2 diabetes mellitus
#1032Anti-interferon-α antibodies
#1033251 human secreted proteins
#1034Anti-interferon-α antibodies
#1035Method of selectively assaying adiponectin multimers
#1036Methods for predicting development of auto-immune diseases and treatment of same
#1037Computer systems and methods for inferring casuality from cellular constituent abundance data
#1038Methods for treating diabetes and related disorders using pde10a inhibitors
#1039Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1040Method for detecting GAD65 autoreactive T cells newly diagnosed type1 diabetic patients and in the prediabetic period
#1041Assessing insulin resistance using biomarkers
#1042Method and device for assessment of a series of glucose concentration values of a body fluid of a diabetic for adjustment of insulin dosing
#1043Crystals of DPP-IV
#1044Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
#1045Method for diagnosing diabetes type 2 using standardized mixed meal and calculated index values
#1046Methods for identifying compounds for treating diabetes mellitus
#1047Methods of modulating β cell function
#1048Treatment and Diagnosis of Insulin-Resistant States
#1049Methods of diagnosing & treating diabetes and insulin resistance
#1050WSX receptor agonist antibodies
#1051Monitoring two dimensions of diabetes pathogenesis
#1052Complement C3 precursor biopolymer markers predictive of type II diabetes
#1053Method for diagnosing insulin resistance from nasal secretions
#1054Use of saposin-related proteins for preventing and treating obesity, diabetes and/or metabolic syndrome
#1055Glycosyl phosphatidyl inositol specific phospholipase D proteins and uses thereof
#1056Antibodies to PRO1561 polypeptide
#1057Method of screening for drugs that block ligand binding to a lipid binding protein
#1058Methods, products and treatments for diabetes
#1059Methods of treatment of feeding disorders or disorders of glucose uptake and for modifying metabolism and identifying therapeutic reagents therefor
#1060Modulation of the synthesis of insulin
#1061CD39L3 and its role in diabetes
#1062Receptor
#1063Computer systems and methods for inferring causality from cellullar constituent abundance data
#1064Use of dg153 secreted protein products for preventing and treating pancreatic disease and/or obesity and/or metabolic syndrome
#1065Method of screening activators and/or inhibitors of insulin receptor substrate 2
#1066Protein for diagnosing diabetic retinopathy
#1067Methods of MHC class II epitope mapping, detection of autoimmune T cells and antigens, and autoimmune treatment
#1068Method of evaluating a subject for risk or predisposition of reduced renal function over time
#1069Use of dg008,dg065,dg210 or dg239 secreted protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome
#1070Methods for the treatment of insulin resistance and disease states characterized by insulin resistance
#1071Methods for distinguishing type-1 from type-2 diabetes
#1072Methods of diagnosing and treating diabetes and insulin resistance
#1073Methods of detecting a phenotype of a polymorphic protein
#1074Methods of diagnosing and treating diabetes and insulin resistance
#1075Compositions and methods for preventing, treating and diagnosing diabetes
#1076Method for assessing arteriosclerosis and diabetic nephropathy
#1077Antibodies to PRO1275 polypeptide
#1078Diagnostic composition for diabetes type-2 and impaired glucose tolerance, and methods of use
#1079Complement C3 precursor biopolymer markers predictive of type II diabetes
#1080Glucose-transport related genes, polypeptides, and methods of use thereof
#1081Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level
#1082Computational knowledge model to discover molecular causes and treatment of diabetes mellitus
#1083System and method for determining insulin bolus quantities
#1084Methods, assays and compositions for treating retinol-related diseases
#1085Proteins involved in the regulation of energy homeostasis
#1086Pharmaceutical compositions comprising CB1 cannabinoid receptor antagonists and potassium channel openers for the treatment of obesity and related conditions
#1087Glycated insulin as a biomarker for diagnosis and monitoring of diabetes
#1088Preventives/remedies for neurodegenerative diseases
#1089Compositions and methods for the treatment of body weight disorders, including obesity
#1090Agonists and antagonists of ryzn for the treatment of metabolic disorders
#1091Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1092Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1093THE PRO4979 POLYPEPTIDE
#1094RAGE fusion proteins and methods of use
#1095Methods of diagnosing & treating diabetes and insulin resistance
#1096Antibodies to PRO 1120 polypeptide
#1097Human diabetes-mediating proteins
#1098Method and index for diagnosing insulin resistance
#1099Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
#1100Biological markers for longevity and diseases and uses thereof
#1101Use of sglt homolog
#1102Cross-beta structure comprising amyloid-binding proteins and methods for detection of the cross-beta structure, for modulating cross-beta structures fibril formation and for modulating cross-beta structure-mediated toxicity
#1103Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1104Method for detecting the risk of and for treatment of type 2 diabetes
#1105Screening method
#1106Therapeutic use of resveratrol for hyperglycemia
#1107Assay
#1108Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity
#1109Use of a fibroblast growth factor-binding protein for the treatment and diagnosis of diabetic wound healing problems
#1110Method for diagnosing diabetes in a mammal
#1111Multimarker panel based on PIGF for diabetes types 1 and 2
#1112Unc-13 in the modulation of neurotransmission and secretion events
#1113Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles
#1114Methods for identifying compounds for treating diabetes mellitus
#1115Skrp, astray, string, vacm associated with metabolic control
#1116Methods of identifying biomarkers
#1117Method for diagnosing type II diabetes or monitoring therapeutic effects of therapeutic agents for type II diabetes
#1118RIP140 regulation of glucose transport
#1119Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles
#1120PRO 1384 antibodies
#1121Resistin as a marker and therapeutic target for cardiovascular disease
#1122Dynamic hepatic recycling glucose tolerance test
#1123Pancreas-specific proteins
#1124Method for detecting lysosomal storage diseases
#1125Method, composition and device for treating starch related diseases
#1126Method of detecting mild impaired glucose tolerance or insulin secretory defect
#1127Diagnosis and treatment of early pre-Type-1 diabetes utilizing glial fibrillary acidic protein
#1128Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1129Diagnosis and therapy of conditions by detection or modulation of the alms1 gene or protein
#113050 human secreted proteins
#1131RBP4 in insulin sensitivity/resistance, diabetes, and obesity
#1132Methods and reagents for diagnosis and treatment of diabetes
#1133Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1134Human Type II diabetes gene - Kv channel-interacting protein (KChIP1) located on chromosome 5
#1135Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1136Compositions and methods of using hexokinase V
#1137Treatment and diagnosis of insulin-resistant states
#1138Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1139Rat model of diabetic nephropathy
#1140Nucleic acid encoding GAD65
#1141Secreted and transmembrane polypetides and nucleic acids encoding the same
#1142Compositions, kits and methods for identification and modulation of type I diabetes
#1143Methods and compositions for preventing obesity and obesity related disorders
#1144Methods for diagnosing and treating autoimmune disease
#1145Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1146Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1147Screening for gestational disorders
#1148Methods of treating insulin resistance with an inhibitor of an NAD(P)H oxidase
#1149Intracellular signaling pathways in diabetic subjects
#1150Screening method
#1151Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1152Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1153Soluble transferrin receptor
#1154Adipocytes and uses thereof
#1155Diagnosis and treatment of early pre-type-1 diabetes utilizing neuronal proteins
#1156Type1 diabetes diagnostics and therapeutics
#1157Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1158Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1159Methods for predicting development of insulin resistance
#1160Proteins in diabetes proteome anlysis
#1161Methods for diagnosis and therapy of autoimmune disease, such as insulin dependent diabetes mellitus, involving retroviral superantigens
#1162Methods for diabetes susceptibility assessment in asymptomatic patients
#1163Ligands, including antibodies, showing reactivity against endocrine cells
#1164Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
#1165Mammalian protein phosphatases
#1166Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1167Screening method
#1168Systems and methods for characterizing a biological condition or agent using precision gene expression profiles
#1169Agonists and antagonists of moxifin for the treatment of metabolic disorders
#1170Methods and compositions comprising FATP5 for use in the diagnosis and treatment of metabolic disorders
#1171Biomarkers for differentiating between type 1 and type 2 diabetes
#1172Method for diagnosing or monitoring carbohydrate metabolism disorders
#1173Phosphoprotein target for insulin and its antagonists
#1174Methods and kits for assays of rapid screening of diabetes
#1175Soluble rage protein
#1176Compositions and methods of treating diabetes
#1177Methods of monitoring and modulating LKB1 activity and its downstream targets
#1178Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules and/or insulin
#1179Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1180WSX receptor agonist antibodies
#1181Methods and compositions for determination of glycated proteins
#1182Lactate dehydrogenase as a novel target and reagent for diabetes therapy
#1183Therapeutic polypeptides, nucleic acids encoding same, and methods of use
#1184Therapeutic methods for reducing fat deposition and treating associated conditions
#1185Methods for identifying Rheb effectors as lead compounds for drug development for diabetes and diseases associated with abnormal cell growth
#1186Methods of using quantitative lipid metabolome data
#1187Compounds and methods for assaying activity of lysosomal storage diseases
#1188Peptides for use in treatment and diagnosis of type 1 diabetes
#1189Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
#1190Methods for identifying compounds for treating type 1 diabetes